Portnoy Law Firm Announces Class Action on Behalf of Ultragenyx Pharmaceutical, Inc. Investors
· portnoy law
AI Briefing
- Ultragenyx Pharmaceutical, Inc. investors to file class action lawsuit over securities purchases between August 3, 2023 and December 26, 2025.
- Class action lawsuit seeks damages for alleged wrongdoing.
- Investors have until April 6, 2026 to file lead plaintiff motion.
Advertisement